Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

4 Nov 2011 07:00

RNS Number : 4856R
Biome Technologies PLC
04 November 2011
 



4 November 2011

Biome Technologies plc

("the Group")

Trading Update

Biome Technologies plc today issues a trading update for the nine months ended 30 September 2011.

Highlights

·; Group revenue of £15.3m in the nine months to 30 September 2011 up 49% compared with the same period in 2010

·; Third quarter revenues of £4.3m within the Bioplastics Division 61% ahead of third quarter 2010

·; Closing cash position at 30 September 2011 was £3.0m

·; Group trading performance remains in line with the Board's expectations for the year

Trading Update

Group revenues were £15.3m in the nine months to 30 September 2011 (Q3 2010: £10.3m). This reflected a 110% increase in bioplastic sales made by the UK based Biome Bioplastics, a 34% increase in sales in Stanelco RF Technologies division and a 29% increase in third party sales at the Biotec joint venture. The Group's cash position at 30 September 2011 was £3.0m (30 June 2011: £3.6m).

Bioplastics Division

Revenues in the Bioplastics Division increased from £8.5m to £12.9m in the nine months to 30 September 2011. This was comprised of revenues of £5.3m at Biome Bioplastics and £7.6m from 3rd party sales at the Biotec joint venture in the period.

In the third quarter, Biotec revenues were £2.7m (Q3 2010: £1.7m) benefiting from further abatement of capacity constraints in the supply chain and allowing some stock build within the business. Biome Bioplastics has achieved substantial growth in 2011 compared to comparative quarters in 2010. Q3 sales were £1.7m (Q3 2010 £0.9m). We continue to expect some quarterly volatility as the market reacts to easing of supply constraints.

Stanelco RF Technologies Division

The Stanelco RF Technologies Division continues to perform in line with management expectations with revenues increasing by 34% to £2.4m in the nine months to 30 September 2011. Phasing of sales of furnaces has been skewed to H1 in 2011 and Q3 revenues were £0.6m, below the £0.8m of Q3 2010. Progress continues to be made in broadening the business reach in the industrial marketplace.

Outlook

Trading performance remains in line with the Board's expectations for the year and we are well placed to continue delivering on our strategy through the remainder of 2011 and into 2012.

 

-Ends-

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer 

Declan Brown, Group Finance Director

Tel: +44 (0) 2380 867 100

 

Daniel Stewart & Company plc

Oliver Rigby (Nomad)

Martin Lampshire (Broker)

 

Tel: +44 (0) 20 7776 6550

FTI Consulting

Oliver Winters

Latika Shah

Tel: +44 (0) 20 7831 3113

 

 

 

Notes to Editor:

 

Admitted to AIM in July 2010, the activities of Biome operate in two divisions; Biome Bioplastics and Stanelco RF Technologies. Both divisions are underpinned by the Group's skills in the commercialisation and development of innovative technology.

 

The Group's core strategy is to develop and broaden its bioplastics business organically and is engaged with a variety of large-scale international customers and partners on a number of key commercial and development partnerships. These target applications in the food, horticulture and the electronics markets, amongst others, further enhance the Group's existing and new product development.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKNDQOBDDPDK
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.